Asarfi Hospital's Q1 FY27 investor update highlights impressive growth across financials and operations.

Revenue soared 33.2% YoY to ₹47.53 Cr, with PAT jumping 36.7% to ₹4.27 Cr, underscoring strong profitability with a 19.9% EBITDA margin.

The company expanded Super-Specialty bed capacity and boosted Cancer Unit occupancy to 56%. Key operational gains include robust IPD/OPD revenue surges and a ~28% increase in surgeries.

Strategic physician outreach, marketing, and advanced tech integration (Varian TruBeam, Philips Azurion5) are driving patient volumes.

A planned migration to the BSE Main Board further signals growth ambitions.